Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Other financing activities: 2021-2024

Historic Other financing activities for C4 Therapeutics (CCCC) over the last 4 years, with Dec 2024 value amounting to $382,000.

  • C4 Therapeutics' Other financing activities fell 44.78% to $164,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $571,000, marking a year-over-year decrease of 11.20%. This contributed to the annual value of $382,000 for FY2024, which is 3.80% up from last year.
  • According to the latest figures from FY2024, C4 Therapeutics' Other financing activities is $382,000, which was up 3.80% from $368,000 recorded in FY2023.
  • Over the past 5 years, C4 Therapeutics' Other financing activities peaked at $382,000 during FY2024, and registered a low of -$109,000 during FY2021.
  • For the 3-year period, C4 Therapeutics' Other financing activities averaged around $373,333, with its median value being $370,000 (2022).
  • As far as peak fluctuations go, C4 Therapeutics' Other financing activities spiked by 439.45% in 2022, and later fell by 0.54% in 2023.
  • C4 Therapeutics' Other financing activities (Yearly) stood at -$109,000 in 2021, then spiked by 439.45% to $370,000 in 2022, then fell by 0.54% to $368,000 in 2023, then climbed by 3.80% to $382,000 in 2024.